OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone574-268-6379
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$57.56 million
Profitability
Miscellaneous
Employees80
Next Earnings Date3/4/2020 (Estimated)
OptionableNot Optionable
Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions
What is Orthopediatrics' stock symbol?
Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS."
How were Orthopediatrics' earnings last quarter?
Orthopediatrics Corp (NASDAQ:KIDS) posted its earnings results on Thursday, November, 7th. The company reported ($0.18) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.17) by $0.01. The firm earned $20.74 million during the quarter, compared to analyst estimates of $19.87 million. Orthopediatrics had a negative return on equity of 12.12% and a negative net margin of 15.80%. The company's revenue for the quarter was up 31.1% on a year-over-year basis. During the same quarter last year, the business posted ($0.15) earnings per share. View Orthopediatrics' Earnings History.
When is Orthopediatrics' next earnings date?
What guidance has Orthopediatrics issued on next quarter's earnings?
Orthopediatrics updated its fourth quarter 2019
Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $19-19 million, compared to the consensus revenue estimate of $18.24 million.
What price target have analysts set for KIDS?
5 brokers have issued 12-month price objectives for Orthopediatrics' shares. Their forecasts range from $44.00 to $54.00. On average, they expect Orthopediatrics' share price to reach $49.00 in the next year. This suggests a possible upside of 2.5% from the stock's current price. View Analyst Price Targets for Orthopediatrics.
What is the consensus analysts' recommendation for Orthopediatrics?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthopediatrics.
Has Orthopediatrics been receiving favorable news coverage?
News articles about KIDS stock have been trending extremely negative on Tuesday, InfoTrie reports. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Orthopediatrics earned a media sentiment score of -4.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Orthopediatrics.
Are investors shorting Orthopediatrics?
Orthopediatrics saw a drop in short interest during the month of December. As of December 13th, there was short interest totalling 947,000 shares, a drop of 11.5% from the November 28th total of 1,070,000 shares. Based on an average daily trading volume, of 76,400 shares, the days-to-cover ratio is presently 12.4 days. Approximately 9.7% of the company's shares are short sold. View Orthopediatrics' Current Options Chain.
Who are some of Orthopediatrics' key competitors?
Some companies that are related to Orthopediatrics include Cantel Medical (CMD), Irhythm Technologies (IRTC), Glaukos (GKOS), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), Cardiovascular Systems (CSII), AtriCure (ATRC), Silk Road Medical (SILK), Atrion (ATRI), Shockwave Medical (SWAV), Tactile Systems Technology (TCMD), Cryolife (CRY), Luminex (LMNX), Axonics Modulation Technologies (AXNX) and Orthofix Medical (OFIX).
What other stocks do shareholders of Orthopediatrics own?
Who are Orthopediatrics' key executives?
Orthopediatrics' management team includes the folowing people:
- Mr. Mark C. Throdahl, Pres, CEO & Director (Age 68)
- Mr. Fred L. Hite, CFO & Director (Age 51)
- Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 49)
- Mr. David R. Bailey, Exec. VP (Age 40)
- Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 49)
When did Orthopediatrics IPO?
(KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.
Who are Orthopediatrics' major shareholders?
Orthopediatrics' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (4.48%) and Brasada Capital Management LP (0.06%). Company insiders that own Orthopediatrics stock include Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Kevin Unger and Mark C Throdahl. View Institutional Ownership Trends for Orthopediatrics.
Which major investors are selling Orthopediatrics stock?
KIDS stock was sold by a variety of institutional investors in the last quarter, including Brasada Capital Management LP. Company insiders that have sold Orthopediatrics company stock in the last year include David R Bailey and Mark C Throdahl. View Insider Buying and Selling for Orthopediatrics.
Which major investors are buying Orthopediatrics stock?
How do I buy shares of Orthopediatrics?
Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Orthopediatrics' stock price today?
One share of KIDS stock can currently be purchased for approximately $47.80.
How big of a company is Orthopediatrics?
Orthopediatrics has a market capitalization of $799.22 million and generates $57.56 million in revenue each year. The company earns $-12,020,000.00 in net income (profit) each year or ($0.96) on an earnings per share basis. Orthopediatrics employs 80 workers across the globe.View Additional Information About Orthopediatrics.
What is Orthopediatrics' official website?
How can I contact Orthopediatrics?
Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected]
MarketBeat Community Rating for Orthopediatrics (NASDAQ KIDS)
MarketBeat's community ratings are surveys of what our community members think about Orthopediatrics and other stocks. Vote "Outperform" if you believe KIDS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KIDS will underperform the S&P 500 over the long term. You may vote once every thirty days.
